Table 3.
Major systems involved in the study population
S. NO | Major Systems Involved | Pregnancy N = 112 | Post-partum N = 16 | Total N = 128 | Percentage (%) |
---|---|---|---|---|---|
I | Hypertensive Disorders of Pregnancy | 25 | 8 | 33 | 25.7 |
Severe Preeclampsia | 7 | 1 | 8 | ||
HELLP syndrome | 5 | 1 | 6 | ||
Eclampsia | 13 | 6 | 17 | ||
II | Cardiovascular disease | 29 | 0 | 29 | 22.6 |
Valvular heart disease | 12 | 12 | |||
Congenital heart disease | 5 | 5 | |||
Prosthetic heart valve | 5 | 5 | |||
Pulmonary artery hypertension | 4 | 4 | |||
Cardiomyopathy | 2 | 2 | |||
Heart block | 1 | 1 | |||
II | Neurological Disease | 14 | 2 | 16 | 12.5 |
Seizure disorder | 7 | 7 | |||
Intracranial haemorrhage | 0 | 1 | 1 | ||
Meningoencephalitis | 1 | 1 | |||
GBS (Guillain–Barre syndrome) | 2 | 2 | |||
Cerebral venous thrombosis | 1 | 1 | 2 | ||
Quadriparesis—Barter’s syndrome | 1 | 1 | |||
Transverse myelitis | 1 | 1 | |||
Idiopathic intracranial hypertension | 1 | 1 | |||
IV | Infectious Disease | 9 | 3 | 12 | 9.4 |
COVID-19 | 5 | 5 | |||
Dengue | 2 | 2 | |||
Sepsis | 1 | 3 | 4 | ||
Cellulitis | 1 | 1 | |||
V | Haematological Disease | 9 | 2 | 11 | 8.6 |
Pancytopenia | 4 | 4 | |||
ITP (Ideopathic Thrombocytopenia) | 3 | 3 | |||
DIC (Disseminated intravascular Coagulation) | 0 | 2 | 2 | ||
Severe anaemia | 1 | 1 | |||
VI | Gastrointestinal disease | 8 | 1 | 9 | 7.1 |
Chronic liver disease | 2 | 2 | |||
Non-cirrhotic portal fibrosis | 4 | 4 | |||
Acute Fatty Liver of Pregnancy (AFLP) | 1 | 1 | 2 | ||
Pancreatitis | 1 | 1 | |||
VII | Connective tissue disorder | 7 | 0 | 7 | 5.4 |
Systemic Lupus Erythematosus | 6 | 6 | |||
Takayasu arteritis | 1 | 1 | |||
VIII | Renal disease—CKD | 6 | 0 | 6 | 4.7 |
IX | Endocrinological disorder | 4 | 0 | 4 | 3.1 |
Diabetic Ketoacidosis | 2 | 2 | |||
Hyperthyroidism | 1 | 1 | |||
Primary adrenal insufficiency | 1 | 1 | |||
X | Poisoning (oleander seed) | 1 | 0 | 1 | 0.8 |